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AbstrACt
Objectives The association between psychosocial 
stressors (PS) and chronic kidney disease (CKD) among 
sub-Saharan African (SSA) populations is unknown. We 
examined the association between PS and CKD prevalence 
among rural and urban Ghanaians and Ghanaian migrants 
living in three European cities. We also assessed if the 
influence of PS on CKD is partially mediated by primary 
risk factors (hypertension and diabetes) of CKD.
Design A multi-centred cross sectional data from the 
Research on Obesity and Diabetes among African Migrants 
study.
setting Rural and urban Ghana and three European cities 
(Amsterdam, Berlin and London).
Participants A random sample of 5659 adults (Europe 
3167, rural Ghana 1043 and urban Ghana 1449) aged 
25–70 years.
Explanatory measures PS defined by negative life 
events, perceived discrimination, perceived stress at work/
home and depressive symptoms. Three CKD outcomes 
were considered using the 2012 Kidney Disease: 
Improving Global Outcomes severity of CKD classification. 
Comparisons between PS and CKD outcomes were made 
using logistic regression analyses across all sites.
results We observed higher proportion of negative life 
events (68.7%) and perceived permanent stress (15.9%) 
among Ghanaians living in Ghana than Ghanaians living 
in Europe. Depressive symptoms (7.5%) and perceived 
discrimination (29.7%) were more common among 
Ghanaians living in Europe than Ghanaians living in Ghana. 
No significant association was observed between any of 
the PS constructs and CKD outcomes across sites except 
for positive association between stress at work/home 
and albuminuria (2.81, 95% CI 1.46 to 5.40) and CKD risk 
(2.78, 95% CI 1.43 to 5.43) among Ghanaians living in 
Berlin.
Conclusion Our study found a positive association 
between stress at work/home and albuminuria and CKD 
risk. There was no convincing evidence of associations 
between the other PS constructs and the prevalence of 
CKD risk. Further studies are needed to identify potential 
factors driving the high prevalence of CKD among these 
populations.
IntrODuCtIOn
Worldwide, chronic kidney disease (CKD) is a 
leading cause of mortality and morbidity with 
several risk factors (diabetes mellitus, obesity, 
hypertension and cardiovascular disease).1 
The epidemiological transition in low-income 
and middle-income countries shows increased 
burden of these risk factors.2–4 CKD’s high 
morbidity and mortality is mostly driven by 
uncontrolled comorbidities such as diabetes 
strengths and limitations of this study
 ► This study used all three categories of chronic kid-
ney disease (CKD) definitions (albuminuria, reduced 
estimated glomerular filtration rate and CKD risk) by 
Kidney Disease: Improving Global Outcomes 2012 
in assessing association of psychosocial stressors 
(PS) with CKD across all sites. This provided more 
detailed information on CKD outcomes. 
 ► All sites in our study used well-standardised study 
protocols and this eliminated intraprotocol variability.
 ► The use of four constructs of PS (negative life events, 
perceived discrimination, perceived stress at work/
home and depressive symptoms) provided a robust 
approach to assess PS associations with CKD.
 ► The limitation of intralaboratory variability in earli-
er studies was eliminated using the same standard 
operating procedures in the same laboratory for run-
ning all samples for all sites.
 ► PS is captured and experienced in different magni-
tude across different populations. We  were unable 
to ascertain if PS as defined in this study was ad-
equately captured among Ghanaians living in rural 
and urban Ghana.
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and hypertension.5 6 CKD treatment and management 
cost is very high and not sustainable even in high-income 
countries and this underscores the need for prevention.7 
Available literature has shown that both individual and 
community level economic factors influence CKD.8–10 
However, after adjusting for both individual and commu-
nity level socioeconomic position, differences in CKD 
risk among different populations remained.8 10 11 These 
findings seem to suggest that other social environmental 
factors may be driving CKD prevalence and progression 
in high-risk populations. Recent studies have shown that 
whereas Ghanaians living in Europe have a higher CKD 
risk compared with their host nation populations, they 
have a lower CKD risk compared with their peers living 
in urban Ghana.12 The increased risk of CKD observed 
in urban Ghana was not fully explained by conventional 
risk factors12 and socioeconomic status.13 This under-
scores the need to identify other modifiable risk factors 
of CKD for prevention, optimum treatment and efficient 
management.
Evidence shows that where an individual works or stays 
influences his or her physiological well-being leading to 
an increased risk of chronic diseases.14 15 Thus, migrants’ 
physiological well-being is influenced by the environ-
ment (host nations) they move to stay. The association 
between psychosocial stressors (PS) and CKD as well as 
the biological pathways through which PS influences 
CKD progression is poorly understood and complex,5 
although several pathways have been suggested.16 17 
Specifically, PS have been reported to be associated with 
alteration in the sympathetic/autonomic nervous system 
activity leading to higher rates of traditional risk factors of 
CKD including hypertension and diabetes.18–20 Environ-
mental stressors have been reported to contribute to the 
development of insulin resistance, metabolic syndrome, 
obesity and diabetes, which if uncontrolled leads to CKD 
incidence.21 22 Other studies23 24 have suggested that 
stress attributable to social and/or economic disadvan-
tage is associated with CKD development and progres-
sion through an interaction between other psychosocial 
factors and comorbid behaviours such as alcohol, tobacco 
and drug use.25 In addition, undernutrition due to stress 
adversely impact on fetal environment by impeding fetal 
growth leading to low birth weight, which has been shown 
to be associated with CKD in adult life.25 26
However, studies linking PS to CKD prevalence and 
progression vary greatly among different geographical 
populations.5 16 27–31 Specifically, in the USA whereas no 
association was found between PS and CKD,31–33 another 
study reported lower prevalence of CKD was associ-
ated with greater life stressors at baseline.31 In contrast, 
in the Netherlands depressive and anxiety symptoms 
were observed to be common among patients with 
CKD and such patients had increased risk of poor clin-
ical outcomes.28 Similarly, a study conducted in Korea 
reported a positive relationship between depressive 
symptoms and CKD.27 These observations suggest differ-
ential impact of PS at different geographical locations. 
For example, discrimination among migrants may differ 
greatly between host population and from their sub-Sa-
haran African (SSA) compatriots. Specifically, some 
studies have reported differences in PS among rural and 
urban populations.34
Current literature on the association between PS and 
CKD among SSA populations and their migrants in 
Europe is scanty and uncertain. We therefore sought to 
determine the association between PS and CKD preva-
lence among Ghanaians in rural and urban Ghana and 
their migrants living in three European cities. Further-
more, we examined the influence of PS on risk factors 
(obesity, diabetes and hypertension) of CKD.
MEthODs
study population and study design
For this study, data from the Research on Obesity & 
Diabetes among African Migrants (RODAM) study, a 
multicentre cross-sectional study, were used. The ratio-
nale, conceptual framework, design and methodology 
of the RODAM study have been described in detail else-
where.12 13 35 36 To summarise, the study was conducted 
from 2012 to 2015. Ghanaians aged 25–70 years living 
in rural and urban communities in Ghana as well as in 
three European cities (Amsterdam, Berlin and London) 
were included in this study. We standardised data collec-
tion across all sites. Informed consent was obtained from 
each participant prior to enrolment in the study. In 
Ghana, participants were randomly drawn from a list of 
30 enumeration areas in the Ashanti region based on the 
2010 population census. These enumeration areas came 
from both rural areas and two purposively selected urban 
cities (Kumasi and Obuasi). For Ghanaians in Amsterdam, 
we randomly drew participants from the Municipal 
register. This register holds data on country of birth of 
citizens and their parents, thus allowing for sampling 
based on the Dutch standard indicator for ethnic origin. 
London lacked a population register for migrant groups. 
Thus, Ghanaian organisations served as sampling frame 
for the study. Lists of these organisations were obtained 
from the Ghanaian Embassy and the Association of 
Ghanaian Churches in the UK in the boroughs known to 
have the greatest concentration of Ghanaians. Members 
were selected from the lists of all members of these organ-
isations. In Berlin, the registration office of the federal 
state of Berlin provided a list of Ghanaian individuals in 
Berlin but this resulted in low response rate. Because of 
this, a change was made to use lists of Ghanaian churches 
and organisations as the sampling frame. Across all sites 
in Europe, all selected participants were sent a written 
invitation combined with written information (infor-
mation sheet) regarding the study and a response card. 
The participants were contacted by phone to schedule a 
date and location of the interview with a trained research 
assistant or opt for the self-administration of the paper 
questionnaire or digital online version depending on the 
preference of the participant. After the completion of the 
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questionnaire, a date for physical examination was then 
scheduled after a positive response. The participants were 
instructed to fast from 22:00 hours the night before the 
physical examination. The response rate was 76% in rural 
Ghana and 74% in urban Ghana. In London, of those 
individuals who were registered in the various Ghanaian 
organisations and were invited, 75% agreed and partici-
pated in the study, while in Berlin, this figure was 68%, 
and 53% in Amsterdam. For the current study, 5898 
participants with data available on both questionnaire 
data and physical measurements were used. Individuals 
who were outside the age range of 25–70 years (n=239) 
were excluded because not all the study sites had individ-
uals outside this age range resulting in 5659 individuals 
comprising 2492 from rural and urban Ghana and 3167 
from the three European cities. In the conduct of anal-
ysis, we further excluded individuals with no data on CKD 
and all other indicators (n=52), resulting in a data set of 
5607 participants for analysis.
MEAsurEMEnts
Covariates
Demographic and lifestyle factors
For this study, we obtained information on demo-
graphics, educational level and lifestyle factors (smoking 
and physical activity) by questionnaire. Physical exam-
inations were performed across all sites using validated 
devices per standardised operational procedures. Educa-
tional level was based on the highest qualification gained 
either in the Netherlands or in the country of origin and 
was classified into four groups: those who have never 
been to school or had elementary schooling only, those 
with lower vocational schooling or lower secondary 
schooling, those with intermediate vocational schooling 
or intermediate/higher secondary education schooling 
and those with higher vocational schooling or university. 
The four categories were further categorised into three 
categories by combining the second and third catego-
ries. Smoking status was determined from the response 
to the question “Do you smoke at all?” and was classi-
fied into non-smokers and current smokers. Physical 
activity was assessed using the WHO Global Physical 
Activity Questionnaire V.2. Weight was measured in light 
clothing and without shoes with SECA 877 scales to the 
nearest 0.1 kg. Height was measured without shoes with a 
portable stadiometer (SECA 217) to the nearest 0.1 cm. 
Body mass index (BMI) was calculated as weight (kg) 
divided by height squared (m2). Overweight was defined 
as BMI of 25 to <30 kg/m2 and obesity as BMI ≥30 kg/m2. 
Waist circumference was measured in centimetres at the 
midpoint between the lower rib and the upper margin of 
the iliac crest. We used the same assessor for each partic-
ipant in measuring all anthropometrics and each was 
measured twice; the average of the two measurements 
was used for analyses.
Predictor: PS
For this study, four constructs of psychosocial stress 
(discrimination, perceived stress at work or at home, 
negative life events and depressive symptoms) were used 
as explanatory variables.
Perceived discrimination
Everyday discrimination as perceived by participants was 
reported as routinely experiencing instances of unfair 
treatment. We used the Everyday Discrimination Scale 
(EDS). The EDS comprises nine items, which rates the 
frequency at which participants experience daily mistreat-
ment and it focuses on being treated with less courtesy or 
less respect, receiving poorer service than other people 
or being called names or insulted. Participants had the 
option of rating each of the nine items from ‘never’=1 to 
‘very often’=5. The obtained scores were summed and an 
average of the scores was computed to obtain a final score 
of 1–5. This scale was used because it is commonly used 
for self-reported discrimination,37 with consistent high 
reliability among a variety of ethnicities,38 comprising 
African migrants in the Netherlands.39
Perceived stress at work or at home
We defined perceived stress at work or at home as ‘sense 
of irritation, filled with anxiety, or as having difficul-
ties in sleeping because of circumstances at work or at 
home’. We used the psychological stress scale created by 
the INTERHEART study.40 Participants in the study were 
asked about their opinion on frequency of stress at work 
and at home, and could answer ‘never’, ‘some periods’, 
‘several periods’ or ‘continually’. Both answers were then 
combined into a composite score and graded into four 
categories: never experienced to experienced permanent 
stress at home or at work.40 Due to the very small numbers 
in the permanent periods of stress group, we combined 
experienced several periods of stress at home or at work 
and permanent periods of stress at home or at work.
Negative life events
The presence of major negative life events among partic-
ipants was perceived as any event that could cause acute 
stress to an individual. We therefore applied the well-val-
idated and widely used list of threatening experiences 
(LTE).41 42 The scale comprised 12 unpleasant events 
participants perceived to have experienced in the past 
12 months. We used a slightly altered version of LTE 
consisting of nine unpleasant items. We dichotomised 
participants into two groups namely ‘no negative life 
events’ and ‘one or more events’ and participants in the 
second category were expected to have higher levels of 
stress.42
Depressive symptoms
Depressive symptoms were measured by the nine-item 
Patient Health Questionnaire (PHQ-9). The PHQ-9 
consists of nine items, with a response scales 0 ‘not at all’, 
1 ‘on several days’, 2 ‘on more than half of the days’ and 
3 ‘nearly every day’. A participant was considered to be 
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in a significant depressed mood when one or both of the 
items 1 (little interest or pleasure in doing things) and 
2 (feeling down, depressed or hopeless) were answered 
with at least ‘on more than half of the days’, and at least 
five of the nine items were answered with at least ‘on 
more than half of the days’.43
Comorbidity factors
Blood pressure (BP) was measured three times using 
a validated semi-automated device (The Microlife 
WatchBP home) with appropriate cuffs in a sitting posi-
tion after at least 5 min rest. The mean of the last two BP 
measurements was used in the analyses. Hypertension 
was defined as systolic BP 140 mm Hg and/or diastolic 
BP 90 mm Hg, and/or being on antihypertensive medi-
cation treatment, and/or self-reported hypertension. 
Trained research assistants in all sites collected fasting 
venous blood samples according to standard opera-
tion procedures, and then temporarily stored at the 
local research centres. The stored blood samples from 
the local research centres were transported to Berlin, 
Germany, according to standardised procedures, for 
biochemical analyses. This was done to avoid intralabora-
tory variability. Fasting plasma glucose concentration was 
measured using an enzymatic method (hexokinase). We 
defined type 2 diabetes according to the WHO diagnostic 
criteria (fasting glucose 7.0 mmol/L, and/or current use 
of medication prescribed to treat diabetes, and/or self-re-
ported diabetes).44 We assessed concentration of total 
cholesterol using colorimetric test kits. All biochemical 
analyses were performed using an ABX Pentra 400 Chem-
istry Analyzer (ABX Pentra; Horiba 90 ABX, Germany). 
Hypercholesterolaemia was defined as total cholesterol 
level ≥6.22 mmol/L. Serum creatinine concentration (in 
mol/L) was determined by a kinetic colorimetric spectro-
photometric isotope dilution mass spectrometry calibra-
tion method (Roche Diagnostics).
Outcome: CKD prevalence
We asked participants to bring an early morning urine 
sample for the analyses of albuminuria and creatinine 
levels. Urinary albumin concentration (in µmol/L) was 
measured by an immunochemical turbidimetric method 
(Roche Diagnostics). Urinary creatinine concentration 
(in µmol/L) was measured by a kinetic spectrophoto-
metric method (Roche Diagnostics). Extensive quality 
checks were done inclusive of blinded serial measure-
ments. Estimated glomerular filtration rate (eGFR) was 
calculated using the CKD Epidemiology Collaboration 
creatinine equation.45 Urinary albumin-creatinine ratio 
(ACR; expressed in mg/mmol) was calculated by taking 
the ratio between urinary albumin and urinary creati-
nine. eGFR and albuminuria were categorised according 
to the 2012 Kidney Disease: Improving Global Outcomes 
(KDIGO) classification.46 eGFR was categorised as 
follows: G1, 90 mL/min/1.73 m2 (normal kidney func-
tion); G2, 60–89 mL/min/1.73 m2 (mildly decreased); 
G3a, 45–59 mL/min/1.73 m2 (mildly to moderately 
decreased); G3b, 30–44 mL/min/1.73 m2 (moderately 
to severely decreased); G4, 15–29 mL/min/1.73 m2 
(severely decreased) and G5, <15 mL/min/1.73 m2 
(kidney failure). Albuminuria categories were derived 
from ACR and were as follows: A1, <3 mg/mmol (normal 
to mildly increased); A2, 3–30 mg/mmol (moderately 
increased) and A3, >30 mg/mmol (severely increased). 
CKD risk was categorised according to severity of kidney 
disease (green, low risk; yellow, moderately increased 
risk; orange, high risk and red, very high risk) using the 
combination of eGFR (G1–G5) and albuminuria (A1–
A3) levels defined by the 2012 KDIGO guidelines.47 Due 
to the small number of participants in the very high-risk 
category of CKD (n=27), the high and very high-risk 
groups were combined. Because of the small number of 
participants in the severely increased albuminuria cate-
gory (A3, n=62), we defined albuminuria as ACR 3 mg/
mmol by combining the moderately increased (A2) and 
severely increased (A3) categories.
Covariates assessed were age, sex, educational level and 
length of stay in Europe. Length of stay was assessed for 
Ghanaian migrants only. Length of stay was defined as the 
number of years lived in Europe at the time of data collec-
tion. Length of stay was controlled for due to evidence 
suggesting that it influences mental health.48 Other 
covariates were hypertension, obesity and diabetes.
Patient and public involvement
Community leaders were involved in the recruitment 
of patients. These comprised religious communities 
(churches and mosques), endorsement from local key 
leaders and establishing relationships with healthcare 
organisations. We also provided information on the 
study by involving the local media (radio and televi-
sion stations). We sent letters to all selected health and 
community authorities to notify participants of the study. 
Team members were sent to the various communities to 
stay among the community and organise mini clinics for 
a period of 1–2 weeks. Results of the study were dissemi-
nated through seminars, durbars and via radio and tele-
vision stations.
statistical methods
Characteristics of participants were expressed as absolute 
numbers and percentages for categorical variables and 
means and SD for continuous variables. The z-test for 
proportions was used to compare proportions of demo-
graphic and clinical variables among the various sites 
and the independent t-test was also used to test for mean 
differences between the two sites. ORs and their corre-
sponding 95% CIs were estimated by means of binary 
logistic regression analyses to study the associations of 
albuminuria (ACR >3 mg/mmol, A2–A3, moderately to 
severely increased albuminuria), reduced kidney func-
tion (eGFR <60 mL/min/1.73 m2, G3–G5 moderately to 
severely decreased kidney function) and increased CKD 
risk (high and very high CKD risk), with adjustments for 
covariates.49 The Spearman’s correlation was used to test 
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for associations between all four constructs of PS. Three 
models were used to examine the data. Model 1 was 
adjusted for age and sex, model 2 was adjusted for age 
and sex and educational level for Ghanaians living in 
SSA while age, sex, educational level and length of stay 
for Ghanaians living in Europe.50–52 Model 3 was adjusted 
for sex, age, educational level and conventional risk 
factors (hypertension, diabetes, hypercholesterolaemia, 
BMI, physical activity and smoking status) of CKD. The 
analyses were performed for all four constructs of PS 
using individuals who have not experienced either of 
the PS per outcome as reference. All tests were strati-
fied per sites due to interactions, Ghanaians living in 
SSA and Europe; Ghanaians living in rural and urban 
Ghana and Ghanaians living in Amsterdam, Berlin and 
London due to an observed interaction between PS and 
site. Furthermore, the analyses were stratified for those 
with and without obesity, diabetes, hypertension across 
all sites due to interactions between these disease risks. 
P values <0.05 were interpreted as statistically signifi-
cant. All analyses were performed using STATA, V.14.0 
(StataCorp).
rEsults
Characteristics of the study population
Participants characteristics are shown in table 1. Ghana-
ians living in Ghana were significantly older than their 
peers living in Europe (47.7±11.9 vs 46.6±9.9, p=0.006). 
There were more female participants in the Ghana sample 
compared with European sample (67.1% vs 58.5%, 
p=0.001). Ghanaians living in Ghana were significantly 
less educated than those living in Europe. Higher propor-
tion of Ghanaians living in Ghana had experienced nega-
tive life events in the last 12 months compared with their 
peers living in Europe (68.7% vs 59.0%, p=0.001). More 
than half of Ghanaians living in Ghana had experienced 
some stress at home or work whereas only a third of those 
living in Europe had experienced some stress at home 
or work (p=0.001). Permanent stress at home/work 
was fairly the same among Ghanaians living in SSA and 
Europe. Perceived discrimination was significantly higher 
among Ghanaians living in Europe compared with their 
peers living in Ghana (29.7% vs 4.8%, p=0.001). Depres-
sive symptoms were more prevalent among Ghanaians 
living in Europe 7.5% compared with their peers living 
in Ghana 5.1%. Almost all Ghanaians living in Europe 
were first-generation migrants. Ghanaians in Europe 
were significantly more obese, more likely to smoke and 
less physically active compared with their peers living in 
Ghana. Prevalence of hypercholesterolaemia was signifi-
cantly higher, but type 2 diabetes and hypertension were 
significantly lower among Ghanaians living in Ghana 
compared with their peers living in Europe (p=0.001). 
Prevalence of albuminuria, reduced eGRF and CKD risk 
were higher in Ghanaians living in Ghana compared with 
those living in Europe.
Association between Ps and CKD
Figures 1-4 show CKD prevalence by negative life events 
in the past 12 months among Ghanaians living in Ghana 
and Europe. In Europe, CKD prevalence was fairly the 
same among those who had experienced any negative life 
events compared with those who had not in the last 12 
months. Prevalence of CKD was higher among Ghanaians 
who had not experienced any negative life events in the 
past 12 months (10.9%) compared with those who had 
experienced some negative life events (9.9%) and living 
in Ghana. CKD prevalence was higher among Ghanaians 
who had not experienced any form of discrimination 
(10.6%) than those who had (6.7%) in Ghana as well as 
in Europe (figure 2). CKD prevalence was slightly higher 
among Ghanaians who had experienced several/perma-
nent stress at work/home in the past 12 months and living 
in Ghana (10.4%) or Europe (9.7%) (figure 3). Ghana-
ians who did not report any form of depressive symptoms 
had a significantly higher CKD prevalence than those 
who did and living in Ghana (10.4%) and Europe (8.7%) 
(figure 4).
Table 2 shows the correlation matrix between the four 
constructs of PS among Ghanaians living in Ghana and 
those living in Europe. All four constructs of PS were posi-
tively correlated with each other among Ghanaians living 
in Europe and Ghanaians living in Ghana (p<0.001), 
except stress at work/home and discrimination among 
Ghanaians living in Ghana.
Table 3 shows association between all four constructs 
of PS and CKD among Ghanaians living in Ghana and 
those living in Europe. There was no statistically signif-
icant association between PS and albuminuria, reduced 
eGFR and CKD risk among Ghanaians living in Ghana 
and those living in Europe except individuals living in 
Europe with some stress and lower risk of reduced eGFR 
(0.46, 95% CI 0.24 to 0.88). Online supplementary table 
S1 shows further adjustments for conventional risk factors 
of CKD. This did not show any statistically significant 
associations between PS and albuminuria, reduced eGFR 
and CKD risk among Ghanaians living in Ghana and 
Europe. Online supplementary table S2 shows further 
stratification based on obesity status. We did not find 
any association between PS and CKD for obese partici-
pants and those who were not obese for Ghanaians living 
in rural and urban Ghana and those living in Europe. 
However, we observed an inverse association between PS 
and CKD among migrants who were not obese but have 
experienced discrimination for the past 12 months (0.63 
95% CI 0.41 to 0.97). In online supplementary table S3, 
we stratified our analysis based on diabetic status. We did 
not find any associations between PS and CKD for partic-
ipants with and without diabetes for both Ghanaians 
living in rural and urban Ghana and their migrant peers 
in Europe. Finally, online supplementary table S4 strati-
fied analysis by hypertension status. No associations were 
observed between PS and CKD for individuals who had 
hypertension and those who did not have hypertension 
for both those living in rural and urban Ghana as well as 
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Table 1 Baseline characteristics of respondents
Ghanaians (SSA)
n (%)
Ghanaians (Europe)
n (%) P value
N 2492 (44.1) 3167 (55.9) 0.001
Female sex 1672 (67.1) 1851 (58.5) 0.001
Age (years) 47.7±11.9 46.6±9.9 0.006
Educational status
  Low 1169 (49.2) 635 (21.8) 0.001
  Middle 858 (36.1) 1111 (38.1)
  High 347 (14.6) 1168 (40.1)
Negative life events in the past 12 months
  No 739 (31.3) 1158 (41.0) 0.001
  Yes 1619 (68.7) 1667 (59.0)
Perceived stress at home/work
  Never 692 (29.4) 1371 (48.8) 0.001
  Some periods 1290 (54.7) 1033 (36.8)
  Several/Permanent 375 (15.9) 407 (14.4)
Perceived discrimination
  No 2065 (95.2) 1960 (70.3) 0.001
  Yes 104 (4.8) 829 (29.7)
Depressive symptoms
  No 2239 (94.9) 2582 (92.5) 0.001
  Yes 119 (5.1) 209 (7.5)
Migration generation
  First Not applicable 2868 (98.7) Not applicable
  Second Not applicable 38 (1.3) Not applicable
BMI
  Normal (<25 kg/m2) 1373 (55.2) 643 (20.4) 0.001
  Overweight (25≤30 kg/m2) 684 (27.5) 1350 (42.8)
  Obese (>30 kg/m2) 432 (17.3) 1163 (36.8)
  Currently smoking 36 (1.5) 121 (4.1) 0.001
Physical activity 1255 (52.8) 1131 (44.0) 0.001
Hypacholesterolemia 352 (14.2) 354 (11.3) 0.007
Type 2 diabetes 206 (8.3) 444 (14.0) 0.001
Hypertension 837 (33.6) 1801 (56.9) 0.001
ACR
  A1<3 mg/mmol 2215 (90.2) 2814 (91.8) 0.001
  A2–A3≥3 mg/mmol 243 (9.8) 252 (8.2)
eGFR
  G1–G2≥60 mL/min/1.73 m2 2377 (96.3) 2936 (97.4) 0.018
  G3a–G5<60 mL/min/1.73 m2 85 (3.7) 78 (2.6)
CKD risk
  Low risk 2197 (89.6) 2705 (91.5) 0.015
  Moderate-to-very high risk 256 (10.4) 252 (8.5)
A1, normal to mildly increased; A2–A3, moderately increased to severely increased; ACR, albumin creatinine ratio; BMI, body mass index; 
CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; G1–G2, normal to high kidney function to mildly decreased; G3a–G5, 
mildly to moderately decreased to kidney failure; N, number of respondents; SSA, sub-Saharan Africa.
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their compatriots living in Europe. An inverse association 
was observed between PS and CKD among Ghanaians who 
have experienced discrimination in the last 12 months 
with no hypertension and living in Europe (0.51, 95% CI 
0.27 to 0.97). Also, we observed that having experienced 
some stress at home/work was inversely associated with 
reduced eGFR among Ghanaians with hypertension and 
living in Europe (0.47, 95% CI 0. 0.23 to 0.95).
Table 4 shows associations between all 4 constructs of 
PS and CKD stratified by Ghanaians living in urban and 
rural Ghana. There was no association between PS and 
albuminuria, reduced eGFR and CKD risk among Ghana-
ians living rural and urban Ghana.
Table 5 shows associations between all four constructs of 
PS and CKD stratified by Ghanaians living in Amsterdam, 
Berlin and London. There were no associations between 
PS and albuminuria, reduced eGFR and CKD risk among 
Ghanaians living in Europe except for positive associa-
tion between stress at work/home and albuminuria (2.81, 
95% CI 1.46 to 5.40) and CKD risk (2.78, 95% CI 1.43 to 
5.43) among Ghanaians living in Berlin.
DIsCussIOn
Key findings
Whereas there was an association between those who 
have experienced some stress at home/work and reduced 
Figure 1 Prevalence of chronic kidney disease (CKD) 
risk among Ghanaians who have experienced negative life 
events and those who have not experienced any negative life 
events stratified by site. Definition per 2012 Kidney Disease: 
Improving Global Outcomes guidelines.
Figure 2 Prevalence of chronic kidney disease risk among 
Ghanaians who have experienced discrimination and those 
who have not experienced any discrimination stratified by 
site. Definitions per 2012 Kidney Disease: Improving Global 
Outcomes guidelines.
Figure 3 Prevalence of chronic kidney disease (CKD) risk 
among Ghanaians who have experienced stress at home/
work and those who have not experienced any stress 
at home/work in the past 12 months stratified by site. 
Definitions per 2012 Kidney Disease: Improving Global 
Outcomes guidelines.
Figure 4 Prevalence of chronic kidney disease (CKD) risk 
among Ghanaians who have depressive symptoms and 
those who do not have depressive symptoms stratified by 
site. Definitions per 2012 Kidney Disease: Improving Global 
Outcomes guidelines.
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eGFR among Ghanaians living in Europe, we did not 
find any association between PS and CKD among Ghana-
ians living in rural and urban Ghana and their peers in 
Europe. Also, PS was not associated with CKD for those 
living in rural and urban Ghana and neither for those 
living in the three European cities. However, there was 
an association between stress at work/home and albu-
minuria and CKD risk among Ghanaians living in Berlin. 
Further adjustment for conventional risk factors of CKD 
yielded similar results.
Discussion of key findings
Association between PS and CKD in Ghana
Our study did not find any association between any of 
the four constructs of PS and prevalence of CKD (albu-
minuria, reduced eGFR and CKD risk) among Ghanaians 
living in rural and urban Ghana. Our findings are however 
in contrast with earlier studies which reported positive 
associations between PS and prevalent of CKD.28 31 53 
Other studies have hypothesised that the influence of PS 
on CKD may be important in only those with hyperten-
sion and diabetes and that PS may mediate or moderate 
the association between renal functioning and lifestyle 
behaviours such as smoking and physical activity.33 For 
example, they argue that stress enhances sympathetic 
nervous system (SNS) activity to increase glucocorticoid 
secretion and inflammatory cytokines, which heavily 
contribute to hypertension, diabetes and vascular disease, 
which are major risk factors of CKD incidence and prev-
alence.54 The lack of association between PS and CKD in 
this present study is unclear due to lack of literature on 
the association between PS and CKD prevalence, partic-
ularly in rural and urban populations. Worth noting, 
however, is the presence of rich family support systems in 
the Ghanaian context, especially in rural Ghana, which 
may help individuals with CKD to cope with PS thereby 
minimising its effect. For example, patients with limited 
social networks and low social support have been shown 
to have augmented risk of morbidity and mortality.55–57 
Specifically, there is evidence that positive social support 
is a protective factor for persons dealing with long-term 
disease conditions.58 Other studies have reported a 
protective relationship between social networks, emotion-
ally supportive relationship and threats to physiological 
and psychosocial health.59
Association between PS and CKD Amsterdam, Berlin and London
Literature on the association between PS and CKD 
prevalence among migrants is scant and absent in most 
European populations. The lack of positive association 
between PS and CKD in our study is consistent with recent 
studies conducted among African-Americans31 33 and 
other populations.32 60 Specifically, a recent study using 
data from the Jackson Heart Study, which comprised 
extensive constructs of psychosocial variables reported 
that greater life stressors were associated with lower prev-
alence of CKD at baseline.31 Several studies in other parts 
of the world have reported a positive relationship between 
higher prevalence of stressors and CKD risk,27 28 although 
the study findings have been inconsistent. Whereas some 
did not find any associations among African-Americans,31 
others found associations in other populations. Even 
among those who found some associations the directions 
differed.28 Reasons for the lack of association observed 
in our study among migrants are not fully understood 
but may reflect the real-world situation. First, migrants 
from Ghana practice both nuclear and extended family 
support system as their peers living in rural and urban, 
this practice may mitigate the impact of stressors such as 
unemployment, death of a love one, discrimination, etc. 
They also belong to several religious organisations such as 
churches, which provide similar support systems against 
stressors. Moreover, there are several associations of the 
various ethnic groups (Akan, Ga and Ewe) providing such 
support when the need arises. These systems provide both 
instrumental and/or emotional social support.61 These 
Table 2 Relationship between PS constructs (negative life events, discrimination, stress at work or home and depression) by 
Ghanaians (SSA) and Ghanaians (Europe)
Correlation matrix Negative events Discrimination Stress at work/home Depression
Europe
  Negative events 1.000
  Discrimination 0.152* 1.000
  Stress at work/home 0.297* 0.161* 1.000
  Depressive symptoms 0.143* 0.136* 0.285* 1.000
Ghana
  Negative events 1.000
  Discrimination 0.079* 1.000
  Stress at work/home 0.101* −0.032 1.000
  Depressive symptoms 0.091* 0.042 0.185* 1.000
*Significant at 1%, Spearman’s correlation.
PS, psychosocial stressors; SSA, sub-Saharan Africa.
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assertions are supported by several studies. Specifically, 
these studies have shown that social support positively 
affect health outcomes through mechanisms such as 
increased patient compliance with therapies, decreased 
levels of depressive affect, direct physiological effects on 
the immune system and improved perception of quality of 
life.58 59 The lack of association observed in this study may 
also be attributed to other mechanisms, which influence 
the associations between PS and CKD. Another reason for 
the lack of association between PS and CKD in this study 
could be the cross-sectional analysis of our study. The 
association between PS and CKD has been shown to be 
cumulative and builds over substantial period of time.62 
To effectively evaluate this, longitudinal study design is 
required. This suggests the need for more longitudinal 
studies in future research in assessing the associations 
between PS and CKD outcomes.62 63
strengths and limitations
Our study is the first to use all four robust constructs of 
PS to determine association between PS and CKD. This 
gave our study a more robust definition of PS compared 
with other similar studies. The use of all three definitions 
of CKD per KDIGO guidelines also provided a broader 
definition of CKD and allowed comparison between 
different geographical regions. The use of a homoge-
nous population of Ghanaians and standardised proto-
cols and diagnostic criteria in this study also provided a 
novel opportunity to compare Ghanaians living in rural 
and urban Ghana and their compatriots living in Europe. 
There are limitations to our study. The effect of PS on 
CKD has been reported to be cumulative and takes a 
long period of time, therefore the use of cross-sectional 
design prevented us from determining the longitudinal 
and cumulative effect of repeated exposure to PS among 
the two populations. PS is captured and experienced in 
different magnitude across different populations. We 
were unable to ascertain if PS as defined in this study was 
adequately captured among Ghanaians living in rural and 
urban Ghana. Lastly, the four PS measures were assessed 
separately because of multicollinearity among the 
measures. There are several methods of addressing multi-
collinearity among measures such as partial least squares 
regression, principal component analysis, data reduction 
technique, which when used could have influenced the 
interpretation of the study results.
COnClusIOn
We identified positive association between stress at work/
home and albuminuria and CKD risk among Ghanaians 
living in Berlin. Conversely, our study shows no associ-
ations between stress as indicated by four PS indicators 
and prevalence of CKD. Consequently, there is the need 
to explore other factors that may be responsible for the 
observed differences in the prevalence of CKD among 
Ghanaians living in rural and urban Ghana and their 
peers living in Europe.
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